Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Biotechnology     Life Sciences Research     Proteomics     Proteomics Reagents    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

European Proteomics Reagents Market

  • Report Code: PR 1002
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The European proteomics reagents market is driven by the increase in collaboration between companies & research institutes and the increasing investments in R&D in this sector. The market was valued at $1.23 billion in 2012, and is expected to reach $ 2.23 billion by 2018, at a CAGR of 10.30%.

 

The report ‘European proteomics reagents Market Forecast, 2012-2018’ analyzes the market in terms of product type, such as immunoassay, microarray, spectroscopy, electrophoresis, x-ray crystallography, chromatography, and protein fractionation. These market segments have experienced high growth, owing to an increased awareness for sophisticated diagnostic techniques. The immunoassay segment accounted for the largest share in the overall market, followed by microarray. The protein fractionation market segment is expected to grow at the fastest CAGR of 14.10%, during the forecast period. Germany has the largest share in the European proteomics reagents market.

 

Europe accounted for the second-largest share in the global proteomics reagents market. Huge capital investments are required for proteomics research. The governments in various European countries are allocating thematic priorities, and numerous organizations are putting in efforts to nurture the growth of the market. Non-profit organizations were established to coordinate national activities in the proteomics field, and numerous companies collaborated for proteomics research.

 

The report provides an extensive competitive landscaping of the leading companies operating in this market. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies, Sigma- Aldrich Corporation, and Bio-Rad laboratories.

 

Furthermore, the details of the segment and country-specific company shares, news and deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies are provided in the report.

 

Customization Options

Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep-dive analysis of the following parameters:

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (segment-wise)
  • Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment levels
  • Applications of the products (segment-wise and country-wise)
  • A comprehensive coverage of product approvals, pipeline products, and product recalls

 

Key Data

  • Units of reagents sold in a particular country
  • The number of diagnostics labs, research labs, and hospitals where the proteomics reagents are used

 

Researcher/Scientist’s Perception Analysis

  • Fast turn-around analysis of researchers’ response to market events and trends
  • Pattern analysis of usage by researchers
  • Researchers’ opinions about products from different companies

 

Product/Brand Perception Matrix

  • Comprehensive study of customers’ perception and behavior through our in-built social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution

 

Pricing Trends

  • Cost analysis of proteomics reagents in the major countries of the region

 

Competitive Intelligence

  • The company share analysis of the top players in the market in this region
  • The crucial developments and strategies that companies inculcate in their portfolios


1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Proteomics Reagents-Europe, By Applications
4.1 Split By Geography
4.1 Proteomics Reagents-Spain by Applications
4.1 Proteomics Reagents-United Kingdom by Applications
4.1 Proteomics Reagents-France by Applications
4.1 Proteomics Reagents-Germany by Applications
4.1 Proteomics Reagents-Italy by Applications
4.1 Proteomics Reagents-Rest of Europe by Applications
4.2 Proteomics Reagents-Diagnosis-Europe
4.2.1 Proteomics Reagents-Diagnosis-Europe, By Technologies
4.2.1.1 Proteomics Reagents-Protein Microarray Reagents-Europe-Diagnosis
4.2.1.2 Proteomics Reagents-Spectroscopy Reagents-Europe-Diagnosis
4.2.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-Europe-Diagnosis
4.2.2 Proteomics Reagents-Diagnosis-Europe, By Geographies
4.2.2.1 Proteomics Reagents-Rest of Europe-Diagnosis
4.2.2.2 Proteomics Reagents-Italy-Diagnosis
4.2.2.3 Proteomics Reagents-Germany-Diagnosis
4.2.2.4 Proteomics Reagents-France-Diagnosis
4.2.2.5 Proteomics Reagents-United Kingdom-Diagnosis
4.2.2.6 Proteomics Reagents-Spain-Diagnosis
4.3 Proteomics Reagents-Drug Discovery-Europe
4.3.1 Proteomics Reagents-Drug Discovery-Europe, By Technologies
4.3.1.1 Proteomics Reagents-Protein Microarray Reagents-Europe-Drug Discovery
4.3.1.2 Proteomics Reagents-Spectroscopy Reagents-Europe-Drug Discovery
4.3.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-Europe-Drug Discovery
4.3.2 Proteomics Reagents-Drug Discovery-Europe, By Geographies
4.3.2.1 Proteomics Reagents-Rest of Europe-Drug Discovery
4.3.2.2 Proteomics Reagents-Italy-Drug Discovery
4.3.2.3 Proteomics Reagents-Germany-Drug Discovery
4.3.2.4 Proteomics Reagents-France-Drug Discovery
4.3.2.5 Proteomics Reagents-United Kingdom-Drug Discovery
4.3.2.6 Proteomics Reagents-Spain-Drug Discovery
5 Proteomics Reagents-Europe, By Technologies
5.1 Split By Geography
5.2 Proteomics Reagents-Spain by Technologies
5.1 Proteomics Reagents-United Kingdom by Technologies
5.1 Proteomics Reagents-France by Technologies
5.1 Proteomics Reagents-Germany by Technologies
5.1 Proteomics Reagents-Italy by Technologies
5.1 Proteomics Reagents-Rest of Europe by Technologies
5.2 Proteomics Reagents-Protein Fractionation Reagents-Europe
5.2.1 Proteomics Reagents-Protein Fractionation Reagents-Europe, By Geographies
5.2.1.1 Proteomics Reagents-Protein Fractionation Reagents-Spain
5.2.1.2 Proteomics Reagents-Protein Fractionation Reagents-United Kingdom
5.2.1.3 Proteomics Reagents-Protein Fractionation Reagents-France
5.2.1.4 Proteomics Reagents-Protein Fractionation Reagents-Germany
5.2.1.5 Proteomics Reagents-Protein Fractionation Reagents-Italy
5.2.1.6 Proteomics Reagents-Protein Fractionation Reagents-Rest of Europe
5.3 Proteomics Reagents-Spectroscopy Reagents-Europe
5.3.1 Proteomics Reagents-Spectroscopy Reagents-Europe, By Applications
5.3.1.1 Proteomics Reagents-Spectroscopy Reagents-Europe-Drug Discovery
5.3.1.2 Proteomics Reagents-Spectroscopy Reagents-Europe-Diagnosis
5.3.2 Proteomics Reagents-Spectroscopy Reagents-Europe, By Geographies
5.3.2.1 Proteomics Reagents-Spectroscopy Reagents-Spain
5.3.2.2 Proteomics Reagents-Spectroscopy Reagents-United Kingdom
5.3.2.3 Proteomics Reagents-Spectroscopy Reagents-France
5.3.2.4 Proteomics Reagents-Spectroscopy Reagents-Germany
5.3.2.5 Proteomics Reagents-Spectroscopy Reagents-Italy
5.3.2.6 Proteomics Reagents-Spectroscopy Reagents-Rest of Europe
5.4 Proteomics Reagents-Chromatography Reagents-Europe
5.4.1 Proteomics Reagents-Chromatography Reagents-Europe, By Geographies
5.4.1.1 Proteomics Reagents-Chromatography Reagents-Spain
5.4.1.2 Proteomics Reagents-Chromatography Reagents-United Kingdom
5.4.1.3 Proteomics Reagents-Chromatography Reagents-France
5.4.1.4 Proteomics Reagents-Chromatography Reagents-Germany
5.4.1.5 Proteomics Reagents-Chromatography Reagents-Italy
5.4.1.6 Proteomics Reagents-Chromatography Reagents-Rest of Europe
5.5 Proteomics Reagents-X-Ray Crystallography Reagents-Europe
5.5.1 Proteomics Reagents-X-Ray Crystallography Reagents-Europe, By Applications
5.5.1.1 Proteomics Reagents-X-Ray Crystallography Reagents-Europe-Drug Discovery
5.5.1.2 Proteomics Reagents-X-Ray Crystallography Reagents-Europe-Diagnosis
5.5.2 Proteomics Reagents-X-Ray Crystallography Reagents-Europe, By Geographies
5.5.2.1 Proteomics Reagents-X-Ray Crystallography Reagents-Spain
5.5.2.2 Proteomics Reagents-X-Ray Crystallography Reagents-United Kingdom
5.5.2.3 Proteomics Reagents-X-Ray Crystallography Reagents-France
5.5.2.4 Proteomics Reagents-X-Ray Crystallography Reagents-Germany
5.5.2.5 Proteomics Reagents-X-Ray Crystallography Reagents-Italy
5.5.2.6 Proteomics Reagents-X-Ray Crystallography Reagents-Rest of Europe
5.6 Proteomics Reagents-Electrophoresis Reagents-Europe
5.6.1 Proteomics Reagents-Electrophoresis Reagents-Europe, By Geographies
5.6.1.1 Proteomics Reagents-Electrophoresis Reagents-Spain
5.6.1.2 Proteomics Reagents-Electrophoresis Reagents-United Kingdom
5.6.1.3 Proteomics Reagents-Electrophoresis Reagents-France
5.6.1.4 Proteomics Reagents-Electrophoresis Reagents-Germany
5.6.1.5 Proteomics Reagents-Electrophoresis Reagents-Italy
5.6.1.6 Proteomics Reagents-Electrophoresis Reagents-Rest of Europe
5.7 Proteomics Reagents-Protein Microarray Reagents-Europe
5.7.1 Proteomics Reagents-Protein Microarray Reagents-Europe, By Applications
5.7.1.1 Proteomics Reagents-Protein Microarray Reagents-Europe-Drug Discovery
5.7.1.2 Proteomics Reagents-Protein Microarray Reagents-Europe-Diagnosis
5.7.2 Proteomics Reagents-Protein Microarray Reagents-Europe, By Geographies
5.7.2.1 Proteomics Reagents-Protein Microarray Reagents-Spain
5.7.2.2 Proteomics Reagents-Protein Microarray Reagents-United Kingdom
5.7.2.3 Proteomics Reagents-Protein Microarray Reagents-France
5.7.2.4 Proteomics Reagents-Protein Microarray Reagents-Germany
5.7.2.5 Proteomics Reagents-Protein Microarray Reagents-Italy
5.7.2.6 Proteomics Reagents-Protein Microarray Reagents-Rest of Europe
5.8 Proteomics Reagents-Immunoassay Reagents-Europe
5.8.1 Proteomics Reagents-Immunoassay Reagents-Europe, By Geographies
5.8.1.1 Proteomics Reagents-Immunoassay Reagents-Spain
5.8.1.2 Proteomics Reagents-Immunoassay Reagents-United Kingdom
5.8.1.3 Proteomics Reagents-Immunoassay Reagents-France
5.8.1.4 Proteomics Reagents-Immunoassay Reagents-Germany
5.8.1.5 Proteomics Reagents-Immunoassay Reagents-Italy
5.8.1.6 Proteomics Reagents-Immunoassay Reagents-Rest of Europe
6 Proteomics Reagents-Europe, By Geographies
6.1 Proteomics Reagents-Spain
6.1.1 Proteomics Reagents-Spain, By Technologies
6.1.1.1 Proteomics Reagents-Protein Microarray Reagents-Spain
6.1.1.2 Proteomics Reagents-Spectroscopy Reagents-Spain
6.1.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-Spain
6.1.1.4 Proteomics Reagents-Electrophoresis Reagents-Spain
6.1.1.5 Proteomics Reagents-Immunoassay Reagents-Spain
6.1.1.6 Proteomics Reagents-Chromatography Reagents-Spain
6.1.1.7 Proteomics Reagents-Protein Fractionation Reagents-Spain
6.1.2 Proteomics Reagents-Spain, By Applications
6.1.2.1 Proteomics Reagents-Spain-Diagnosis
6.1.2.2 Proteomics Reagents-Spain-Drug Discovery
6.2 Proteomics Reagents-United Kingdom
6.2.1 Proteomics Reagents-United Kingdom, By Technologies
6.2.1.1 Proteomics Reagents-Protein Microarray Reagents-United Kingdom
6.2.1.2 Proteomics Reagents-Spectroscopy Reagents-United Kingdom
6.2.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-United Kingdom
6.2.1.4 Proteomics Reagents-Electrophoresis Reagents-United Kingdom
6.2.1.5 Proteomics Reagents-Immunoassay Reagents-United Kingdom
6.2.1.6 Proteomics Reagents-Chromatography Reagents-United Kingdom
6.2.1.7 Proteomics Reagents-Protein Fractionation Reagents-United Kingdom
6.2.2 Proteomics Reagents-United Kingdom, By Applications
6.2.2.1 Proteomics Reagents-United Kingdom-Diagnosis
6.2.2.2 Proteomics Reagents-United Kingdom-Drug Discovery
6.3 Proteomics Reagents-France
6.3.1 Proteomics Reagents-France, By Technologies
6.3.1.1 Proteomics Reagents-Protein Microarray Reagents-France
6.3.1.2 Proteomics Reagents-Spectroscopy Reagents-France
6.3.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-France
6.3.1.4 Proteomics Reagents-Electrophoresis Reagents-France
6.3.1.5 Proteomics Reagents-Immunoassay Reagents-France
6.3.1.6 Proteomics Reagents-Chromatography Reagents-France
6.3.1.7 Proteomics Reagents-Protein Fractionation Reagents-France
6.3.2 Proteomics Reagents-France, By Applications
6.3.2.1 Proteomics Reagents-France-Diagnosis
6.3.2.2 Proteomics Reagents-France-Drug Discovery
6.4 Proteomics Reagents-Germany
6.4.1 Proteomics Reagents-Germany, By Technologies
6.4.1.1 Proteomics Reagents-Protein Microarray Reagents-Germany
6.4.1.2 Proteomics Reagents-Spectroscopy Reagents-Germany
6.4.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-Germany
6.4.1.4 Proteomics Reagents-Electrophoresis Reagents-Germany
6.4.1.5 Proteomics Reagents-Immunoassay Reagents-Germany
6.4.1.6 Proteomics Reagents-Chromatography Reagents-Germany
6.4.1.7 Proteomics Reagents-Protein Fractionation Reagents-Germany
6.4.2 Proteomics Reagents-Germany, By Applications
6.4.2.1 Proteomics Reagents-Germany-Diagnosis
6.4.2.2 Proteomics Reagents-Germany-Drug Discovery
6.5 Proteomics Reagents-Italy
6.5.1 Proteomics Reagents-Italy, By Technologies
6.5.1.1 Proteomics Reagents-Protein Microarray Reagents-Italy
6.5.1.2 Proteomics Reagents-Spectroscopy Reagents-Italy
6.5.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-Italy
6.5.1.4 Proteomics Reagents-Electrophoresis Reagents-Italy
6.5.1.5 Proteomics Reagents-Immunoassay Reagents-Italy
6.5.1.6 Proteomics Reagents-Chromatography Reagents-Italy
6.5.1.7 Proteomics Reagents-Protein Fractionation Reagents-Italy
6.5.2 Proteomics Reagents-Italy, By Applications
6.5.2.1 Proteomics Reagents-Italy-Diagnosis
6.5.2.2 Proteomics Reagents-Italy-Drug Discovery
6.6 Proteomics Reagents-Rest of Europe
6.6.1 Proteomics Reagents-Rest of Europe, By Technologies
6.6.1.1 Proteomics Reagents-Protein Microarray Reagents-Rest of Europe
6.6.1.2 Proteomics Reagents-Spectroscopy Reagents-Rest of Europe
6.6.1.3 Proteomics Reagents-X-Ray Crystallography Reagents-Rest of Europe
6.6.1.4 Proteomics Reagents-Electrophoresis Reagents-Rest of Europe
6.6.1.5 Proteomics Reagents-Immunoassay Reagents-Rest of Europe
6.6.1.6 Proteomics Reagents-Chromatography Reagents-Rest of Europe
6.6.1.7 Proteomics Reagents-Protein Fractionation Reagents-Rest of Europe
6.6.2 Proteomics Reagents-Rest of Europe, By Applications
6.6.2.1 Proteomics Reagents-Rest of Europe-Diagnosis
6.6.2.2 Proteomics Reagents-Rest of Europe-Drug Discovery

Please fill in the form below to receive a free copy of the Summary of this Report
















European Proteomics Reagents Market

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
North American Proteomics North American Proteomics
The North American Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 3.7 billion in 2012 and is expected to be $ 7.49 billion by 2018, at a CAGR of 12.4%. The report “North American Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Sigma-Aldrich Corporation, Danaher Corporation, Water Corporation, etc.
Upcoming
European Proteomics European Proteomics
The European Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 3.28 billion in 2012 and is expected to be $ 7.35 billion by 2018, at a CAGR of 14.6%. The report “European Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Roche, etc.
Upcoming
Asian Proteomics Asian Proteomics
The Asian Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 1.42 billion in 2012 and is expected to be $ 4.16 billion by 2018, at a CAGR of 19.8%. The report “Asian Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Water Corporation, Roche, etc.
Upcoming
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539